Evidence map›Paper›PMID 34771375›Full record

ArticlePolymers2021

Manufacturing and Analysis of Overmolded Hybrid Fiber Polyamide 6 Composite.

Heru S B Rochardjo, Cahyo Budiyantoro

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Heru S B RochardjoDepartment Mechanical and Industrial Engineering, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.ORCID 0000-0003-0126-000X
Cahyo BudiyantoroDepartment of Mechanical Engineering, Universitas Muhammadiyah Yogyakarta, Bantul 55183, Indonesia.
Muhammadiyah University of Yogyakarta · IDUniversitas Gadjah Mada · ID

Funding

Program Desentralisasi dan Kompetitif Nasional Tahun Anggaran 2021 6/E1/KP.PTNBH/2021 and 2200/UN1/DITLIT/DIT-LIT/PT/2021
6 · The paper itself

Abstract

Currently, fiber-reinforced thermoplastic composites are widely applied in structural applications. It has great potential to replace metal structures and provides advantages in weight reduction. In this study, the pretensioned unidirectional carbon fiber was overmolded by Polyamide 6 contained 30%wt of glass fibers (PA 6-30GF). Process parameters such as injection pressure, melting temperature, duration of carbon fiber cryogenic treatment, and fiber pretension were optimized to maximize the flexural strength, impact strength, and interlaminar properties of the hybrid composite. The relationship between factors and responses was analyzed using Box-Behnken design (BBD) from response surface methodology (RSM) and analysis of variance (ANOVA). Three levels were assigned for each factor. There were 27 experimental trials carried out, and a significant regression for the coefficient between the factors was derived. The BBD and ANOVA analysis demonstrate that the predicted values from the model are in satisfactory correlation with the experimental results. The optimum responses found were achieved by setting the following injection molding parameters: melting temperature of 278 °C and injection pressure of 122 bar. Carbon fiber, as a unidirectional reinforcement, should be immersed in liquid nitrogen for 10 min and mounted on the mold in a pretensioned state with a force of 100 N. The combination of these parameters can produce an optimum flexural strength of 248.6 Mpa, impact strength of 173.4 kJ/m

Indexed as

Box–Behnken designcryogenic treatmentflexural strengthhybrid fiberILSSimpact strengthovermoldingpolyamide 6

Identifiers

PMID34771375
PMCPMC8587925
OpenAlexW3210291162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.